Eribulin mesylate use as third-line therapy in patients...

Therapeutic Advances in Medical Oncology 2019 / 01 Vol. 11

Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study

Adamo, Vincenzo, Ricciardi, Giuseppina Rosaria Rita, Giuffrida, Dario, Scandurra, Giuseppa, Russo, Antonio, Blasi, Livio, Spadaro, Pietro, Iacono, Carmelo, Soto Parra, Hector J., Savarino, Antonino, F
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835919895755
Date:
January, 2019
File:
PDF, 294 KB
2019
Conversion to is in progress
Conversion to is failed